Sunitinib Newbury

Sunitinib Newbury is an oral medication used for certain types of cancer treatment. It belongs to a class of drugs known as kinase inhibitors. This product is manufactured by Newbury Pharmaceuticals Ab and is available for oral use.

Sunitinib is primarily used to treat specific cancers, including gastrointestinal stromal tumors and advanced renal cell carcinoma. It may also be prescribed for pancreatic neuroendocrine tumors in some cases. This medication works by slowing or stopping the growth of cancer cells. Patients often ask, 'what is Sunitinib used for' when exploring treatment options.

Sunitinib may help reduce tumor size or slow disease progression in some patients. Common effects include fatigue, nausea, or digestive discomfort during treatment. Individual responses vary, and not all users experience the same effects. It is important to discuss any concerns with a healthcare provider.

Store Sunitinib in a cool, dry place away from direct sunlight. Keep this medication out of reach of children and pets. Avoid crushing or splitting tablets unless directed by a healthcare professional. Always follow the handling instructions provided with the product.

Sunitinib may interact with other medications, including certain antibiotics, antifungals, or heart medications. Alcohol and grapefruit products can also affect how this drug works. Always inform your healthcare provider about all medications and supplements you are taking before starting Sunitinib.